Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB19376ApprovedWithdrawnSmall molecule
Salicylanilide: Overview.
- Mechanism
- Curator reviewed
Pharmacologically active on Epidermal growth factor receptor
- Formula / weight
- C13H11NO2 · 213.236 g/mol (avg)
- Also known as
- 2-hydroxy-n-phenylbenzamide · N-phenylsalicylamide · Salinidol
- Code names
- NSC-14881
Resolves to
Structure
InChIKey
WKEDVNSFRWHDNR-UHFFFAOYSA-NSMILESOC1=CC=CC=C1C(=O)NC1=CC=CC=C1Targets
What you can answer from here — as of September 23, 2026
1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
Which drugs share a target with Salicylanilide, and which of those have an active Phase 3 trial?